Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
The contrast agent (Gd-DTPA, Gadavist) will be injected intravenously (IV) in the arm (patients only). The IV will be inserted by qualified medical professional at CBI. This contrast agent will be standard dose in accordance with its FDA approved labeling and dosing. Controls will NOT be administered the contrast agent.
Age
18–65
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy male or female non-MS control volunteers
You may not be if
Medically unstable or with cardiac, pulmonary, hematological, renal, or hepatic dysfunction.
Current or past DSM-IV diagnosis of major depression, bipolar and psychotic disorders.
Contraindications for MRI, including
Intracranial clips
Metal implants
External metallic devices/objects/clips within 10mm of the head
Suspected or confirmed metal in the eyes (history of welding or similar activity)
Claustrophobia
Cardiac pacemaker or pacing wires
Pregnancy - Pregnancy tests will be offered to women of childbearing age at no cost to the subject
History of moderate to severe head injury, stroke, and seizures.
Alcoholism or drug dependency.
Renal or liver disease as this may cause concerns related to Gd-DTPA contrast agent.
* Allergy to the contrast agent Gadolinium
* Relapses or steroid therapy in patient at or in the month preceding the study
* Patients only
Clareo Health | pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress
